Global enteral syringe market to grow by $444.7m by 2028

The sector is witnessing a demand in clinics and home care settings.

The global enteral syringe market is projected to rise by $444.7m until 2028 at a compound annual growth rate of 5.83%, said Technavio.

The sector’s expansion is attributed to the rising prevalence of pancreatic cancer, bile duct diseases, and gallbladder-related conditions.

“Enteral syringes are essential tools in the treatment of these conditions, particularly in percutaneous procedures for biliary strictures and the identification of non-biliary blocks,” the report said.

The market is also driven by vendors focusing on innovation, particularly in regions like India, China, and Brazil, where enteral syringes are used without stringent regulation. 

Moreover, its demand is increasing in clinics and home care settings for enteral nutrition, particularly amongst the elderly and those with conditions like dysphagia, neurological disorders, and gastrointestinal issues.

“Medical device companies are focusing on safety, efficacy, and user-friendly designs to meet these demands,” it added.